2026
article
OpenAlex
Amro Taha, Avilash Mondal, Harigopal Sandhyavenu, Lalitsiri Atti et autres
us
(code pays fourni par la source)
2026
article
OpenAlex
Hubert B. Haywood, Uchechukwu Ikeaba, Gregg C Fonarow, Haolin Xu et autres
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized cause of heart failure (HF).1,2 Outpatient clinic visits are an important opportunity to optimize guideline-directed medical therapy for the general HF population, as well as specific disease-modifying medications for those with ATTR-CM. Yet, large-scale …
us
(code pays fourni par la source)
2026
article
OpenAlex
Amiya A Ahmed, Amiya A Ahmed, Frederick Lu, Sijian Zhang et autres
Abstract Aims In randomized controlled trials, target-dose angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) improved clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF), although the mortality reduction was not statistically significant. Target doses worsened kidney function, …
us, pl, de, it, Afrique du Sud, co, bo
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Chun Shing Kwok, Adnan I. Qureshi, Richard Paul Steeds, Gregg C Fonarow et autres
BACKGROUND: The influence of sex on the extent of missed opportunities for early diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) has not been characterized. OBJECTIVES: The objective of the study was to determine the rate and causes of hospitalization preceding the index admission …
gb, us
(code pays fourni par la source)